Ublituximab Completed Phase 2 Trials for Multiple Sclerosis Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02738775 | Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis |